“…Twenty-nine studies met the inclusion criteria, involving 35,708 RA patients and 149,421 non-RA controls. Among them, 15 studies ( 5 , 11 , 13 , 22 , 24 , 25 , 27 , 31 , 33 , 34 ) provided ( 37 – 40 , 45 ) prevalence values for hyperthyroidism, 12 provided ( 5 , 11 , 22 , 24 , 31 , 33 , 34 , 36 , 37 , 42 , 44 , 45 ) prevalence values for subclinical hyperthyroidism, 26 provided ( 5 , 11 , 13 , 14 , 22 – 31 , 33 – 41 , 43 , 45 , 46 ) prevalence values for hypothyroidism, and 17 provided ( 5 , 11 , 14 , 22 , 24 , 31 – 34 , 36 – 39 , 42 – 45 ) prevalence values for subclinical hypothyroidism. The NOS checklist was used to evaluate the quality of studies, and 7 studies (24.13%) assessed as high quality, and 18 studies (62.07%) identified as medium quality.…”